Seasonal Influenza Vaccine Antigens

In February and September of each year, the World Health Organization (WHO) convenes with its network of advisors to decide on flu vaccine formulations for the northern and southern hemispheres, respectively. To support ongoing vaccine reformulation programmes, The Native Antigen Company develops season-specific antigens to support vaccine and diagnostic manufacturers.

Our Antigens

To support vaccine research and development, The Native Antigen Company has developed Haemagglutinin (HA) and Neuraminidase (NA) antigens for the WHO-recommended egg-based and recombinant vaccine strains. Available in bulk quantities, antigens can be used in a range of applications, including immunoassay development and as immunogens.

Expressed from our proprietary VirtuE™ HEK293 expression system, these antigens exhibit proper glycosylation and folding. Our latest Haemagglutinin antigens feature C-terminal T4 foldon domains, stabilising them in their trimeric conformation to present more native-like conformational epitopes.

For more information on our influenza products, click on the product codes below:

H5N1 Strains

Species	Strain description	Protein	GISAID No.	Product Code
Influenza A	A/chicken/Scotland/054477/2021	Nucleoprotein (NP)	EPI1963385	REC32055 >>>
	A/Greylag_goose/England/054503/2021	Nucleoprotein (NP)	EPI1963898	REC32056 >>>
	A/Greylag_goose/Scotland/024915/2022	Nucleoprotein (NP)	EPI2076366	REC32057 >>>
	AA/Duck/Egypt/AR526/2017	Nucleoprotein (NP)	EPI1420358	REC32058 >>>
	A/Cambodia/NPH230032/2023	Nucleoprotein (NP)	EPI2419703	REC32059 >>>
	A/Greylag_goose/Scotland/024915/2022	Hemagglutinin (HA)	EPI2076373	REC32060 >>>
	A/Greylag_goose/Scotland/024915/2022	Neuraminidase (NA)	EPI2076372	REC32061 >>>

2023-2024 Influenza Antigens for Northern Hemisphere Flu Season

Species	Strain description	Antigen	GISAID No.	Product Code
Influenza A	A/Victoria/4897/2022 (H1N1)pdm09-like virus	Hemagglutinin (HA)	EPI2319193	REC32052 >>>
	A/Victoria/4897/2022 (H1N1)pdm09-like virus	Neuraminidase (NA)	EPI2319192	REC32051 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Hemagglutinin (HA)	EPI1859996	REC32002 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1859995	REC32003 >>>
	A/Wisconsin/67/2022 (H1N1)pdm09-like virus	Hemagglutinin (HA)	EPI2224978	REC32054 >>>
	A/Wisconsin/67/2022 (H1N1)pdm09-like virus	Neuraminidase (NA)	EPI2224977	REC32053 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Hemagglutinin (HA)	EPI1859992	REC32020 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1859991	REC32021 >>>
Influenza B	B/Austria/1359417/2021-(B/Victoria lineage)-like virus	Haemagglutinin (HA)	EPI1868375	REC32004 >>>
	B/Austria/1359417/2021-(B/Victoria lineage)-like virus	Neuraminidase (NA)	EPI1868374	REC32005 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Haemagglutinin (HA)	EPI551297	REC32022 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Neuraminidase (NA)	EPI529344	REC31955 >>>

2023 Southern Hemisphere Flu Season Antigens

Species	Strain/Subtype	Antigen	GISAID No.	Product Code
Influenza A	A/Darwin/6/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1885401	REC32021 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1885402	REC32037 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1859995	REC32003 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Hemagglutinin (HA)	EPI1859996	REC32002 >>>
	A/Sydney/5/2021 (H1N1)pdm09-like virus	Neuraminidase (NA)	EPI1942221	REC32040 >>>
	A/Sydney/5/2021 (H1N1)pdm09-like virus	Hemagglutinin (HA)	EPI1942222	REC32038 >>>
	A/Wisconsin/588/2019 (H1N1)pdm09-like virus	Neuraminidase (NA)	EPI1957292	REC32040 >>>
	A/Sydney/5/2021 (H1N1)pdm09-like virus	Hemagglutinin (HA)	EPI1957293	REC32039 >>>
Influenza B	B/Austria/1359417/2021	Haemagglutinin (HA)	EPI1857129	REC32004 >>>
	B/Austria/1359417/2021	Neuraminidase (NA)	EPI1857130	REC32005 >>>
	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Haemagglutinin (HA)	EPI1845793	REC32004 >>>
	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Neuraminidase (NA)	EPI1845794	REC32005 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Neuraminidase (NA)	EPI1857129	REC31955 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Hemagglutinin (HA)	EPI529345	REC32022 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Neuraminidase (NA)	EPI551296	REC31955 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Hemagglutinin (HA)	EPI551297	REC32022 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Neuraminidase (NA)	EPI1885401	REC32021 >>>

2022 Northern Hemisphere Flu Season Antigens

Species	Strain/Subtype	Antigen	Product Code
Influenza A	A/Victoria/2570/2019 (H1N1)pdm09-like virus	Haemagglutinin (HA)	REC32023 >>>
	A/Victoria/2570/2019 (H1N1)pdm09-like virus	Neuraminidase (NA)	REC31950 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Haemagglutinin (HA)	REC32020 >>>
	A/Darwin/6/2021 (H3N2)-like virus	Neuraminidase (NA)	REC32021 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Haemagglutinin (HA)	REC32002 >>>
	A/Darwin/9/2021 (H3N2)-like virus	Neuraminidase (NA)	REC32003 >>>
	A/Wisconsin/588/2019 (H1N1)pdm09-like virus	Haemagglutinin (HA)	REC31200 >>>
	A/Wisconsin/588/2019 (H1N1)pdm09-like virus	Neuraminidase (NA)	REC32025 >>>
Influenza B	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Haemagglutinin (HA)	REC32004 >>>
	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Neuraminidase (NA)	REC32005 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Haemagglutinin (HA)	REC32022 >>>
	B/Phuket/3073/2013 (B/Yamagata lineage)-like virus	Neuraminidase (NA)	REC31955 >>>

2022 Southern Hemisphere Flu Season Antigens

Species	Strain/Subtype	Antigen	Product Code
Influenza A	A/Wisconsin/588/2019 (H1N1)pdm09-like virus	Haemagglutinin (HA)	REC32000 >>>
	A/Wisconsin/588/2019 (H1N1)pdm09-like virus	Neuraminidase (NA)	REC32001 >>>
	A/Darwin/9/2021(H3N2)-like virus	Haemagglutinin (HA)	REC32002 >>>
	A/Darwin/9/2021(H3N2)-like virus	Neuraminidase (NA)	REC32003 >>>
Influenza B	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Haemagglutinin (HA)	REC32004 >>>
	B/Austria/1359417/2021 (B/Victoria lineage)-like virus	Neuraminidase (NA)	REC32005 >>>
	B/Phuket/3073/2013 (B/Yamagata Lineage)-like virus	Haemagglutinin (HA)	REC31954 >>>
	B/Phuket/3073/2013 (B/Yamagata Lineage)-like virus	Neuraminidase (NA)	REC31955 >>>

2021-2022 Northern Hemisphere Flu Season Antigens

Species	Strain/Subtype	Antigen	Product Code
Influenza A	A/Victoria/2570/2019 (H1N1)pdm09-Like	Haemagglutinin (HA)	REC31949 >>>
	A/Victoria/2570/2019 (H1N1)pdm09-Like	Neuraminidase (NA)	REC31950 >>>
	A/Cambodia/e0826360/2020 (H3N2)-Like	Haemagglutinin (HA)	REC31951 >>>
	A/Cambodia/e0826360/2020 (H3N2)-Like	Neuraminidase (NA)	REC31952 >>>
Influenza B	B/Washington/02/2019 (B/Victoria lineage)-Like	Haemagglutinin (HA)	REC31888 >>>
	B/Washington/02/2019 (B/Victoria lineage)-Like	Neuraminidase (NA)	REC31889 >>>
	B/Phuket/3073/2013 (B/Yamagata Lineage)-Like	Haemagglutinin (HA)	REC31954 >>>
	B/Phuket/3073/2013 (B/Yamagata Lineage)-Like	Neuraminidase (NA)	REC31955 >>>

Our Influenza Products

We also offer an extensive range of recombinant HA/NA antigens, native cell lysates and species-specific monoclonal antibodies for established strains.

See Our Full Influenza Range

Our Influenza Services

To support influenza vaccine development, The Native Antigen Company also offers custom services to rapidly develop panels of high quality influenza antigens.

For a bespoke proposal and consultation, please get in touch using the form below

First name

Last name

Email address

What you're looking for

Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below. Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below. Yes please, I would like to stay up to date with the latest infectious disease research and innovations. No thank you, I do not want to hear about the latest infectious disease research and innovations.

9 + 4 =

HITTING A MOVING TARGET

by Bobby Mitchell | 29th March 2023 | Influenza | 0 Comments

By Holge Hannemann, Director of Research, The Native Antigen Company Influenza viruses A and B are a major public health concern, mainly affecting the pharynx, trachea, and sometimes the lungs of millions of people worldwide each year, with symptoms that range from...

Influenza antigens for Northern Hemisphere’s 2023-2024 flu season

by Bobby Mitchell | 14th February 2023 | Influenza | 0 Comments

Most recent figures published by UK Health Security Agency show that the 2022/2023 Influenza season has been worse than any of the past surveillance periods (GOV.UK, 2023), see Figure 1 (below). High level of Influenza incidence...

The Native Antigen Company introduces new range of influenza antigens

by Bobby Mitchell | 18th November 2022 | Influenza | 0 Comments

Season-specific Haemagglutinin and Neuraminidase antigens will support vaccine and diagnostic reformulation programmes New range developed to cover 2023 southern hemisphere flu season Oxford, UK, 14 November 2022: The Native Antigen Company (part of LGC Clinical...

The Yearly Race for an Influenza Vaccine and the Role of Reagents

by James Shore | 17th August 2020 | Disease insight, Immunoassays, Influenza, Services, Vaccines | 0 Comments

In this blog, we explain how seasonal and pandemic influenza vaccines are developed, manufactured and validated, and introduce our contract services for the rapid development of custom influenza reagents.The Influenza Viruses: A Quick Recap The influenza viruses are...